Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Home
Alembic Pharmaceuticals Limited
Press Release May 05 2021
Published May 5 2021
4 min read

Press Release May 05 2021

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 05, 2021, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution USP, 2% and 0.5%.".

View Attachment